FAR Biotech Officially Establishes Wisconsin Presence, Expanding Its QuantumAI Drug Discovery Programs in Madison
FAR Biotech, a computational drug discovery company using proprietary quantum modeling and deep learning AI to tackle high impact diseases with significant unmet medical need, today announced that it has officially moved to Wisconsin.
This move, which marks a key milestone in the company's growth and long-term strategy, reflects a natural progression as FAR Biotech has been collaborating with the McArdle Laboratory for Cancer Research at the University of Wisconsin–Madison School of Medicine and Public Health as well as the Versiti Blood Research Institute in Milwaukee. The company expects to enter into additional collaborations with Wisconsin researchers in the coming months.
